Back to Search
Start Over
Effect of INaL blockers in transgenic mouse models of hypertrophic cardiomyopathy is mutation-specific: severe Ca2+ handling abnormalities as requisite for Ranolazine and GS967 to exert a full efficacy effect
- Source :
- Vascular Pharmacology. 132:106748
- Publication Year :
- 2020
- Publisher :
- Elsevier BV, 2020.
Details
- ISSN :
- 15371891
- Volume :
- 132
- Database :
- OpenAIRE
- Journal :
- Vascular Pharmacology
- Accession number :
- edsair.doi...........865ba03e70204bbb46bd096e2a2e845a
- Full Text :
- https://doi.org/10.1016/j.vph.2020.106748